Ionic mechanisms of cellular electrical and mechanical abnormalities in Brugada syndrome

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 1, 2011, Pages

  Dong, Min ^a   Niklewski, Paul J ^a   Wang, Hong Sheng ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Action potential; Cardiac myocyte; Dynamic clamp; Excitation contraction coupling

Indexed keywords

CALCIUM; TETRODOTOXIN;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; BRUGADA SYNDROME; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL STRUCTURE; ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART REPOLARIZATION; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; REPOLARIZATION; SARCOPLASMIC RETICULUM;

ACTION POTENTIALS; ANIMALS; BRUGADA SYNDROME; CALCIUM; COMPUTER SIMULATION; DOGS; ELECTROPHYSIOLOGY; HEART VENTRICLES; MALE; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; SARCOPLASMIC RETICULUM;

EID: 78651270131     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00079.2010     Document Type: Article

References (37)

1. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2: 429-440, 2005. (Pubitemid 40439292)
2. Baroudi G, Napolitano C, Priori SG, Del Bufalo A, Chahine M. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome. Can J Cardiol 20: 425-430, 2004.
3. 2+ reloading in mammalian ventricular myocytes. J Physiol 559: 593-609, 2004.
4. Benito B, Brugada R, Brugada J, Brugada P. Brugada syndrome. Prog Cardiovasc Dis 51: 1-22, 2008.
5. Brugada P, Benito B, Brugada R, Brugada J. Brugada syndrome: update 2009. Hellenic J Cardiol 50: 352-372, 2009.
6. Brugada P, Brugada J, Brugada R. "Localized" right ventricular morphological abnormalities in patients with the Brugada syndrome: what is their significance? Eur Heart J 22: 982-984, 2001.
7. Catalano O, Antonaci S, Moro G, Mussida M, Frascaroli M, Baldi M, Cobelli F, Baiardi P, Nastoli J, Bloise R, Monteforte N, Napolitano C, Priori SG. Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 30:2241-2248, 2009.
8. Decker KF, Heijman J, Silva JR, Hund TJ, Rudy Y. Properties and ionic mechanisms of action potential adaptation, restitution, and accommodation in canine epicardium. Am J Physiol Heart Circ Physiol 296:H1017-H1026, 2009.
9. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Burashnikov E, Christiansen M, Antzelevitch C. Functional Effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 1: 209-218, 2008.
10. Di Diego JM, Sun ZQ, Antzelevitch C. Ito and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol Heart Circ Physiol 271: H548-H561, 1996.
11. Dong M, Sun X, Prinz AA, Wang HS. Effect of simulated Ito on guinea pig and canine ventricular action potential morphology. Am J Physiol Heart Circ Physiol 291: H631-H637, 2006.
12. Fish JM, Antzelevitch C. Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome. J Cardiovasc Electrophysiol 19: 301-308, 2008.
13. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 112: 3680-3687, 2005. (Pubitemid 43739507)
14. Greenstein JL, Hinch R, Winslow RL. Mechanisms of excitation-contraction coupling in an integrative model of the cardiac ventricular myocyte. Biophys J 90: 77-91, 2006.
15. Greenstein JL, Wu R, Po S, Tomaselli GF, Winslow RL. Role of the calcium-independent transient outward current I(to1) in shaping action potential morphology and duration. Circ Res 87: 1026-1033, 2000.
16. Hund TJ, Rudy Y. Rate dependence and regulation of action potential and calcium transient in a canine cardiac ventricular cell model. Circulation 110: 3168-3174, 2004.
17. Keller DI, Barrane FZ, Gouas L, Martin J, Pilote S, Suarez V, Osswald S, Brink M, Guicheney P, Schwick N, Chahine M. A novel nonsense mutation in the SCN5A gene leads to Brugada syndrome and a silent gene mutation carrier state. Can J Cardiol 21: 925-931, 2005.
18. Krishnan SC, Antzelevitch C. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 69: 277-291, 1991.
19. Liu S, Melchert RB, Kennedy RH. Inhibition of L-type Ca2+ channel current in rat ventricular myocytes by terfenadine. Circ Res 81: 202-210, 1997.
20. + current and causes inherited arrhythmias. Circulation 116: 2260-2268, 2007.
21. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, Dalla Volta S. Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 118: 1203-1209, 1989.
22. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 67: 367-378, 2005.
23. + channels in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 26: 761-769, 1995.
24. Razmi RM. Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 15: 1139-1140, 2004.
25. Sakakibara Y, Wasserstrom JA, Furukawa T, Jia H, Arentzen CE, Hartz RS, Singer DH. Characterization of the sodium current in single human atrial myocytes. Circ Res 71: 535-546, 1992.
26. Shattock MJ, Bers DM. Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. Am J Physiol Cell Physiol 256: C813-C822, 1989.
27. Shaw RM, Rudy Y. Electrophysiologic effects of acute myocardial ischemia. A mechanistic investigation of action potential conduction and conduction failure. Circ Res 80: 124-138, 1997. (Pubitemid 27030377)
28. 2+ dynamics in ventricular myocytes. Prog Biophys Mol Biol 96: 377-398, 2008.
29. 2+ release from the sarcoplasmic reticulum during action potentials in guinea-pig ventricular myocytes. J Physiol 489: 1-17, 1995.
30. Smits JP, Koopmann TT, Wilders R, Veldkamp MW, Opthof T, Bhuiyan ZA, Mannens MM, Balser JR, Tan HL, Bezzina CR, Wilde AA. A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol 38: 969-981, 2005.
31. Sun X, Wang HS. Role of the transient outward current (Ito) in shaping canine ventricular action potential-a dynamic clamp study. J Physiol 564: 411-419, 2005.
32. Takagi M, Aihara N, Kuribayashi S, Taguchi A, Kurita T, Suyama K, Kamakura S, Takamiya M. Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography. Heart 89: 169-174, 2003.
33. Takagi M, Aihara N, Kuribayashi S, Taguchi A, Shimizu W, Kurita T, Suyama K, Kamakura S, Hamada S, Takamiya M. Localized right ventricular morphological abnormalities detected by electron-beam computed tomography represent arrhythmogenic substrates in patients with the Brugada syndrome. Eur Heart J 22: 1032-1041, 2001.
34. 2+] during the cardiac action potential. Circ Res 90: 182-189, 2002.
35. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100: 1660-1666, 1999.
36. Yap YG, Camm AJ. Arrhythmogenic mechanisms of non-sedating antihistamines. Clin Exp Allergy 29, Suppl 3: 174-181, 1999.
37. Zimmer T, Surber R. SCN5A channelopathies - an update on mutations and mechanisms. Prog Biophys Mol Biol 98: 120-136, 2008.